BioCardia (BCDA) Non-Current Deffered Revenue (2016 - 2020)

BioCardia (BCDA) has reported Non-Current Deffered Revenue for 5 consecutive years, with $683000.0 the latest figure, recorded in Q3 2020.

• On a quarterly basis, Non-Current Deffered Revenue fell 1.16% year-over-year to $683000.0 in Q3 2020; TTM through Sep 2020 was $683000.0, a 1.16% decrease from a year earlier, with the FY2019 full-year figure at $691000.0, up 797.4% from the prior year.
• Non-Current Deffered Revenue was $683000.0 for Q3 2020 at BioCardia, down from $689000.0 in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $691000.0 in Q3 2019 and troughed at $56000.0 in Q4 2016.
• A 5-year average of $293500.0 and a median of $82000.0 in 2017 frame the typical range for Non-Current Deffered Revenue.
• Across the five-year window, Non-Current Deffered Revenue fell 4.94% in 2018 and soared 797.4% in 2019, its largest moves.
• Over 5 years, Non-Current Deffered Revenue stood at $56000.0 in 2016, then soared by 44.64% to $81000.0 in 2017, then slipped by 4.94% to $77000.0 in 2018, then soared by 797.4% to $691000.0 in 2019, then decreased by 1.16% to $683000.0 in 2020.
• The last three Non-Current Deffered Revenue figures came in at $683000.0 (Q3 2020), $689000.0 (Q2 2020), and $689000.0 (Q1 2020), per Business Quant data.